In prostate cancer cells, gene reporter assays have been used to show that Wnt-11 increases non-canonical Wnt signaling [15], measured using an ATF2-dependent luciferase reporter [30], and inhibits canonical Wnt (β-catenin/Tcf-dependent) signaling [31]. The gene discussed is WNT11; the disease is prostate cancer.